Clinical efficacy and tolerability of Gosha-jinki-gan, a Japanese traditional herbal medicine, for nocturia

We evaluated the efficacy and tolerability of Gosha-jinki-gan (GJG; 濟生腎氣丸 jì shēng shèn qì wán) in 30 cases of nocturia (夜尿 yè niào) unresponsive to α1-blockers or antimuscarinic drugs. All patients received GJG extract powder (2.5 g) three times a day for 12 weeks as an add-on therapy to α1-blocker...

Full description

Bibliographic Details
Main Authors: Hiroshi Yagi, Kojiro Nishio, Ryo Sato, Gaku Arai, Shigehiro Soh, Hiroshi Okada
Format: Article
Language:English
Published: Elsevier 2016-01-01
Series:Journal of Traditional and Complementary Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2225411014000352
id doaj-84bc11a8b1034a9baf850c8430a035b6
record_format Article
spelling doaj-84bc11a8b1034a9baf850c8430a035b62020-11-24T20:54:18ZengElsevierJournal of Traditional and Complementary Medicine2225-41102016-01-016112612910.1016/j.jtcme.2014.11.021Clinical efficacy and tolerability of Gosha-jinki-gan, a Japanese traditional herbal medicine, for nocturiaHiroshi YagiKojiro NishioRyo SatoGaku AraiShigehiro SohHiroshi OkadaWe evaluated the efficacy and tolerability of Gosha-jinki-gan (GJG; 濟生腎氣丸 jì shēng shèn qì wán) in 30 cases of nocturia (夜尿 yè niào) unresponsive to α1-blockers or antimuscarinic drugs. All patients received GJG extract powder (2.5 g) three times a day for 12 weeks as an add-on therapy to α1-blockers or antimuscarinic drugs. Subjective outcomes assessed by the International Prostate Symptom Score—quality of life, and the benign prostatic hyperplasia impact index and objective outcomes assessed by urinary frequency and the urine production rate at night showed significant improvement after treatment. Moreover, other objective outcomes assessed by maximum flow rates, postvoid residual, serum human atrial natriuretic peptide levels, and urinary 8-hydroxy-2′-deoxyguanosine levels did not change. Adverse events were observed in 10% of cases; however, these events were mild. GJG appears to be a safe and effective potential therapeutic alternative for patients with nocturia unresponsive to α1-blockers or antimuscarinic drugs. Further clinical investigations are required to elucidate the precise pathophysiologic mechanisms of GJG in nocturia.http://www.sciencedirect.com/science/article/pii/S2225411014000352Gosha-jinki-gannocturianocturnal polyuria indexoxidative stress8-OHdG level
collection DOAJ
language English
format Article
sources DOAJ
author Hiroshi Yagi
Kojiro Nishio
Ryo Sato
Gaku Arai
Shigehiro Soh
Hiroshi Okada
spellingShingle Hiroshi Yagi
Kojiro Nishio
Ryo Sato
Gaku Arai
Shigehiro Soh
Hiroshi Okada
Clinical efficacy and tolerability of Gosha-jinki-gan, a Japanese traditional herbal medicine, for nocturia
Journal of Traditional and Complementary Medicine
Gosha-jinki-gan
nocturia
nocturnal polyuria index
oxidative stress
8-OHdG level
author_facet Hiroshi Yagi
Kojiro Nishio
Ryo Sato
Gaku Arai
Shigehiro Soh
Hiroshi Okada
author_sort Hiroshi Yagi
title Clinical efficacy and tolerability of Gosha-jinki-gan, a Japanese traditional herbal medicine, for nocturia
title_short Clinical efficacy and tolerability of Gosha-jinki-gan, a Japanese traditional herbal medicine, for nocturia
title_full Clinical efficacy and tolerability of Gosha-jinki-gan, a Japanese traditional herbal medicine, for nocturia
title_fullStr Clinical efficacy and tolerability of Gosha-jinki-gan, a Japanese traditional herbal medicine, for nocturia
title_full_unstemmed Clinical efficacy and tolerability of Gosha-jinki-gan, a Japanese traditional herbal medicine, for nocturia
title_sort clinical efficacy and tolerability of gosha-jinki-gan, a japanese traditional herbal medicine, for nocturia
publisher Elsevier
series Journal of Traditional and Complementary Medicine
issn 2225-4110
publishDate 2016-01-01
description We evaluated the efficacy and tolerability of Gosha-jinki-gan (GJG; 濟生腎氣丸 jì shēng shèn qì wán) in 30 cases of nocturia (夜尿 yè niào) unresponsive to α1-blockers or antimuscarinic drugs. All patients received GJG extract powder (2.5 g) three times a day for 12 weeks as an add-on therapy to α1-blockers or antimuscarinic drugs. Subjective outcomes assessed by the International Prostate Symptom Score—quality of life, and the benign prostatic hyperplasia impact index and objective outcomes assessed by urinary frequency and the urine production rate at night showed significant improvement after treatment. Moreover, other objective outcomes assessed by maximum flow rates, postvoid residual, serum human atrial natriuretic peptide levels, and urinary 8-hydroxy-2′-deoxyguanosine levels did not change. Adverse events were observed in 10% of cases; however, these events were mild. GJG appears to be a safe and effective potential therapeutic alternative for patients with nocturia unresponsive to α1-blockers or antimuscarinic drugs. Further clinical investigations are required to elucidate the precise pathophysiologic mechanisms of GJG in nocturia.
topic Gosha-jinki-gan
nocturia
nocturnal polyuria index
oxidative stress
8-OHdG level
url http://www.sciencedirect.com/science/article/pii/S2225411014000352
work_keys_str_mv AT hiroshiyagi clinicalefficacyandtolerabilityofgoshajinkiganajapanesetraditionalherbalmedicinefornocturia
AT kojironishio clinicalefficacyandtolerabilityofgoshajinkiganajapanesetraditionalherbalmedicinefornocturia
AT ryosato clinicalefficacyandtolerabilityofgoshajinkiganajapanesetraditionalherbalmedicinefornocturia
AT gakuarai clinicalefficacyandtolerabilityofgoshajinkiganajapanesetraditionalherbalmedicinefornocturia
AT shigehirosoh clinicalefficacyandtolerabilityofgoshajinkiganajapanesetraditionalherbalmedicinefornocturia
AT hiroshiokada clinicalefficacyandtolerabilityofgoshajinkiganajapanesetraditionalherbalmedicinefornocturia
_version_ 1716794961356128256